Downregulation of cytokeratin 18 is
associated with paclitaxel-resistance and tumor aggressiveness in
prostate cancer
BO YIN, MO ZHANG, YU ZENG, YOUQIANG LI, CHAO ZHANG,
YONGSHENG SONG
[Related article:] Int
J Oncol 48: 1730–1736, 2016; DOI: 10.3892/ijo.2016.3396
After the publication of the article, the authors
noted that they would like to add Dr Robert H. Getzenberg's name to
the authors' list and as a co-corresponding author, upon the
agreement of all the authors. The correct author list should be as
follows:
BO YIN1, MO ZHANG1, YU
ZENG2,3*, YOUQIANG LI3, CHAO
ZHANG1, ROBERT H. GETZENBERG3* and YONGSHENG
SONG1*
1Department of Urology, Shengjing Hospital
of China Medical University, Shenyang, Liaoning 110004;
2Department of Urology, The First Hospital of China
Medical University, Shenyang, Liaoning 110001, P.R. China;
3James Buchanan Brady Urological Institute, The Johns
Hopkins University School of Medicine, Baltimore, MD 21087, USA
Correspondence should now be addressed to:
Correspondence to: Dr Yongsheng Song, Department of Urology,
Shengjing Hospital of China Medical University, 36 Sanhao Street,
Shenyang, Liaoning 110004, P.R. China, E-mail: yinbowzf@163.com
Dr Robert H. Getzenberg, James Buchanan Brady
Urological Institute, The Johns Hopkins University School of
Medicine, Baltimore, MD 21087, USA, E-mail: getzenberg@outlook.com
*Contributed equally
